390 related articles for article (PubMed ID: 20173137)
21. Post-contrast CT liver attenuation alone is superior to the liver-spleen difference for identifying moderate hepatic steatosis.
Pickhardt PJ; Blake GM; Moeller A; Garrett JW; Summers RM
Eur Radiol; 2024 Jun; ():. PubMed ID: 38834787
[TBL] [Abstract][Full Text] [Related]
22. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
[TBL] [Abstract][Full Text] [Related]
23. Comparison of CT methods for determining graft steatosis in living donor liver transplantation.
Şeker M; Erol C; Sevmiş Ş; Saka B; Durur Karakaya A
Abdom Radiol (NY); 2019 Jul; 44(7):2418-2429. PubMed ID: 30937504
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio.
Rogier J; Roullet S; Cornélis F; Biais M; Quinart A; Revel P; Bioulac-Sage P; Le Bail B
Liver Transpl; 2015 May; 21(5):690-5. PubMed ID: 25761371
[TBL] [Abstract][Full Text] [Related]
25. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy.
Nishino M; Hayakawa K; Nakamura Y; Morimoto T; Mukaihara S
AJR Am J Roentgenol; 2003 Jan; 180(1):129-34. PubMed ID: 12490491
[TBL] [Abstract][Full Text] [Related]
26. Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics.
Haentjens P; Massaad D; Reynaert H; Peeters E; Van Meerhaeghe A; Vinken S; Poppe K; Velkeniers B
Acta Clin Belg; 2009; 64(6):483-93. PubMed ID: 20101871
[TBL] [Abstract][Full Text] [Related]
27. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.
Graffy PM; Sandfort V; Summers RM; Pickhardt PJ
Radiology; 2019 Nov; 293(2):334-342. PubMed ID: 31526254
[TBL] [Abstract][Full Text] [Related]
28. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
Haberal KM; Turnaoğlu H; Haberal Reyhan AN
Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
[TBL] [Abstract][Full Text] [Related]
29. Low-dose unenhanced CT for IV contrast bolus timing: is it reliable to assess hepatic steatosis?
Husarik DB; Boll DT; Nelson RC; Merkle EM
Acad Radiol; 2011 Jul; 18(7):822-7. PubMed ID: 21530330
[TBL] [Abstract][Full Text] [Related]
30. CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
Byun J; Lee SS; Sung YS; Shin Y; Yun J; Kim HS; Yu ES; Lee SG; Lee MG
Eur Radiol; 2019 Aug; 29(8):4427-4435. PubMed ID: 30569183
[TBL] [Abstract][Full Text] [Related]
31. Single-energy non-contrast hepatic steatosis criteria applied to virtual non-contrast images: is it still highly specific and positively predictive?
Haji-Momenian S; Parkinson W; Khati N; Brindle K; Earls J; Zeman RK
Clin Radiol; 2018 Jun; 73(6):594.e7-594.e15. PubMed ID: 29526439
[TBL] [Abstract][Full Text] [Related]
32. Opportunistic Screening for Hereditary Hemochromatosis With Unenhanced CT: Determination of an Optimal Liver Attenuation Threshold.
Lawrence EM; Pooler BD; Pickhardt PJ
AJR Am J Roentgenol; 2018 Dec; 211(6):1206-1211. PubMed ID: 30300001
[TBL] [Abstract][Full Text] [Related]
33. Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation.
Kutaiba N; Richmond D; Morey M; Brennan D; Rotella JA; Ardalan Z; Goodwin M
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):431-438. PubMed ID: 30874372
[TBL] [Abstract][Full Text] [Related]
34. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
Abele JT; Fung CI
Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
[TBL] [Abstract][Full Text] [Related]
35. Quantification of liver fat content with ultrasonographic attenuation measurement function: Correlation with unenhanced multidimensional computerized tomography.
Cerit M; Şendur HN; Cindil E; Erbaş G; Yalçın MM; Cerit ET; Allahverdiyeva S; Oktar SÖ; Yücel C
Clin Imaging; 2020 Sep; 65():85-93. PubMed ID: 32387801
[TBL] [Abstract][Full Text] [Related]
36. X-ray attenuation of the liver and kidney in cats considered at varying risk of hepatic lipidosis.
Lam R; Niessen SJ; Lamb CR
Vet Radiol Ultrasound; 2014; 55(2):141-6. PubMed ID: 24131209
[TBL] [Abstract][Full Text] [Related]
37. Unenhanced computed tomography for non-invasive diagnosis of hepatic steatosis with low tube potential protocol.
Choi Y; Kim DK; Youn SY; Kim H; Choi JI
Quant Imaging Med Surg; 2022 Feb; 12(2):1348-1358. PubMed ID: 35111629
[TBL] [Abstract][Full Text] [Related]
38. Hepatic Steatosis: CT-Based Prevalence in Adults in China and the United States and Associations With Age, Sex, and Body Mass Index.
Guo Z; Blake GM; Graffy PM; Sandfort V; Summers RM; Li K; Xu S; Chen Y; Zhou J; Shao J; Jiang Y; Qu H; Li B; Cheng X; Pickhardt PJ
AJR Am J Roentgenol; 2022 May; 218(5):846-857. PubMed ID: 34817193
[No Abstract] [Full Text] [Related]
39. Comparison of CT methods for determining the fat content of the liver.
Kodama Y; Ng CS; Wu TT; Ayers GD; Curley SA; Abdalla EK; Vauthey JN; Charnsangavej C
AJR Am J Roentgenol; 2007 May; 188(5):1307-12. PubMed ID: 17449775
[TBL] [Abstract][Full Text] [Related]
40. Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations.
Jawahar A; Gonzalez B; Balasubramanian N; Adams W; Goldberg A
Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1389-1396. PubMed ID: 28957871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
